These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 23594590)

  • 1. Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity.
    Schäfer N; Lohmann C; Winnik S; van Tits LJ; Miranda MX; Vergopoulos A; Ruschitzka F; Nussberger J; Berger S; Lüscher TF; Verrey F; Matter CM
    Eur Heart J; 2013 Dec; 34(45):3515-24. PubMed ID: 23594590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid receptor throughout the vessel: a key to vascular dysfunction in obesity.
    Pojoga LH; Baudrand R; Adler GK
    Eur Heart J; 2013 Dec; 34(45):3475-7. PubMed ID: 23666249
    [No Abstract]   [Full Text] [Related]  

  • 3. Mineralocorticoid receptors modulate vascular endothelial function in human obesity.
    Hwang MH; Yoo JK; Luttrell M; Kim HK; Meade TH; English M; Segal MS; Christou DD
    Clin Sci (Lond); 2013 Dec; 125(11):513-20. PubMed ID: 23786536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance.
    Wada T; Ishikawa A; Watanabe E; Nakamura Y; Aruga Y; Hasegawa H; Onogi Y; Honda H; Nagai Y; Takatsu K; Ishii Y; Sasahara M; Koya D; Tsuneki H; Sasaoka T
    J Endocrinol; 2017 Dec; 235(3):179-191. PubMed ID: 28855315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone-induced oxidative stress and inflammation in the brain are mediated by the endothelial cell mineralocorticoid receptor.
    Dinh QN; Young MJ; Evans MA; Drummond GR; Sobey CG; Chrissobolis S
    Brain Res; 2016 Apr; 1637():146-153. PubMed ID: 26923165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mineralocorticoid receptor/Rho/Rho-kinase pathway in obesity-related renal injury.
    Tokuyama H; Wakino S; Hara Y; Washida N; Fujimura K; Hosoya K; Yoshioka K; Hasegawa K; Minakuchi H; Homma K; Hayashi K; Itoh H
    Int J Obes (Lond); 2012 Aug; 36(8):1062-71. PubMed ID: 22184057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice.
    DeMarco VG; Habibi J; Jia G; Aroor AR; Ramirez-Perez FI; Martinez-Lemus LA; Bender SB; Garro M; Hayden MR; Sun Z; Meininger GA; Manrique C; Whaley-Connell A; Sowers JR
    Hypertension; 2015 Jul; 66(1):99-107. PubMed ID: 26015449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice.
    Pojoga LH; Adamová Z; Kumar A; Stennett AK; Romero JR; Adler GK; Williams GH; Khalil RA
    Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H1776-88. PubMed ID: 20363891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice.
    Hirata A; Maeda N; Hiuge A; Hibuse T; Fujita K; Okada T; Kihara S; Funahashi T; Shimomura I
    Cardiovasc Res; 2009 Oct; 84(1):164-72. PubMed ID: 19505930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptor antagonism in experimental atherosclerosis.
    Rajagopalan S; Duquaine D; King S; Pitt B; Patel P
    Circulation; 2002 May; 105(18):2212-6. PubMed ID: 11994257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice.
    Armani A; Cinti F; Marzolla V; Morgan J; Cranston GA; Antelmi A; Carpinelli G; Canese R; Pagotto U; Quarta C; Malorni W; Matarrese P; Marconi M; Fabbri A; Rosano G; Cinti S; Young MJ; Caprio M
    FASEB J; 2014 Aug; 28(8):3745-57. PubMed ID: 24806198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension.
    Quaschning T; Ruschitzka F; Shaw S; Lüscher TF
    Hypertension; 2001 Feb; 37(2 Pt 2):801-5. PubMed ID: 11230376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineralocorticoid receptor agonists induce mouse aortic aneurysm formation and rupture in the presence of high salt.
    Liu S; Xie Z; Daugherty A; Cassis LA; Pearson KJ; Gong MC; Guo Z
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1568-79. PubMed ID: 23661677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
    Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M
    Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction.
    Schäfer A; Fraccarollo D; Hildemann SK; Tas P; Ertl G; Bauersachs J
    Cardiovasc Res; 2003 Jun; 58(3):655-62. PubMed ID: 12798439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.
    Pojoga LH; Yao TM; Opsasnick LA; Siddiqui WT; Reslan OM; Adler GK; Williams GH; Khalil RA
    J Pharmacol Exp Ther; 2015 Oct; 355(1):32-47. PubMed ID: 26183312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of endothelial function in a murine model of mild cholesterol-induced atherosclerosis by mineralocorticoid antagonism.
    Kratz MT; Schirmer SH; Baumhäkel M; Böhm M
    Atherosclerosis; 2016 Aug; 251():291-298. PubMed ID: 27439215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice.
    Keidar S; Hayek T; Kaplan M; Pavlotzky E; Hamoud S; Coleman R; Aviram M
    J Cardiovasc Pharmacol; 2003 Jun; 41(6):955-63. PubMed ID: 12775976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effect of mineralocorticoid receptor antagonism on vascular function in healthy older adults.
    Hwang MH; Yoo JK; Luttrell M; Kim HK; Meade TH; English M; Talcott S; Jaffe IZ; Christou DD
    Exp Gerontol; 2016 Jan; 73():86-94. PubMed ID: 26639352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone Negatively Regulates Nrf2 Activity: An Additional Mechanism Contributing to Oxidative Stress and Vascular Dysfunction by Aldosterone.
    Rodrigues D; Costa TJ; Silva JF; Neto JTO; Alves JV; Fedoce AG; Costa RM; Tostes RC
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.